Evidence map›Paper›PMID 25462894›Full record

ArticlePsychoneuroendocrinology2015

Blunted glucocorticoid and mineralocorticoid sensitivity to stress in people with diabetes.

Livia A Carvalho, Livia Urbanova, Mark Hamer, Ruth A Hackett, Antonio I Lazzarino, Andrew Steptoe

Open access · hybridAbstract read
In one paragraph

Article in Psychoneuroendocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Glucocorticoid Receptor Signaling in Diabetes.International journal of molecular sciences · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Livia A CarvalhoDepartment of Epidemiology and Public Health, University College London, 1-19 Torrington Place, Rm356a, London WC1E 6BR, UK. Electronic address: livia.a.carvalho@ucl.ac.uk.
Livia UrbanovaDepartment of Epidemiology and Public Health, University College London, 1-19 Torrington Place, Rm356a, London WC1E 6BR, UK.
Mark HamerDepartment of Epidemiology and Public Health, University College London, 1-19 Torrington Place, Rm356a, London WC1E 6BR, UK.
Ruth A HackettDepartment of Epidemiology and Public Health, University College London, 1-19 Torrington Place, Rm356a, London WC1E 6BR, UK.
Antonio I LazzarinoDepartment of Epidemiology and Public Health, University College London, 1-19 Torrington Place, Rm356a, London WC1E 6BR, UK.
Andrew SteptoeDepartment of Epidemiology and Public Health, University College London, 1-19 Torrington Place, Rm356a, London WC1E 6BR, UK.
University College London · GB

Funding

British Heart Foundation RG/10/005/28296British Heart Foundation RG/10/05/28296
6 · The paper itself

Abstract

Psychological stress may contribute to type 2 diabetes but mechanisms are still poorly understood. In this study, we examined whether stress responsiveness is associated with glucocorticoid and mineralocorticoid sensitivity in a controlled experimental comparison of people with type 2 diabetes and non-diabetic participants. Thirty-seven diabetes patients and 37 healthy controls underwent psychophysiological stress testing. Glucocorticoid (GR) and mineralocorticoid sensitivity (MR) sensitivity were measured by dexamethasone- and prednisolone-inhibition of lipopolysaccharide (LPS)-induced interleukin (IL) 6 levels, respectively. Blood pressure (BP) and heart rate were monitored continuously, and we periodically assessed salivary cortisol, plasma IL-6 and monocyte chemotactic protein (MCP-1). Following stress, both glucocorticoid and mineralocorticoid sensitivity decreased among healthy controls, but did not change in people with diabetes. There was a main effect of group on dexamethasone (F(1,74)=6.852, p=0.013) and prednisolone (F(1,74)=7.295, p=0.010) sensitivity following stress at 45 min after tasks. People with diabetes showed blunted stress responsivity in systolic BP, diastolic BP, heart rate, IL-6, MCP-1, and impaired post-stress recovery in heart rate. People with Diabetes had higher cortisol levels as measured by the total amount excreted over the day and increased glucocorticoid sensitivity at baseline. Our study suggests that impaired stress responsivity in type-2 diabetes is in part due to a lack of stress-induced changes in mineralocorticoid and glucocorticoid sensitivity.

Indexed as

AgedBlood PressureChemokine CCL2DexamethasoneDiabetes Mellitus, Type 2FemaleGlucocorticoidsHeart RateHumansHydrocortisoneHypothalamo-Hypophyseal SystemInterleukin-6MaleMiddle AgedPituitary-Adrenal SystemPrednisoloneChemokine CCL2DexamethasoneGlucocorticoidsHydrocortisoneInterleukin-6PrednisoloneAcute stressAuto-immune diseasesCardiovascularCorticosteroid sensitivityCytokinesHPA axis

Identifiers

PMID25462894
PMCPMC4275581
OpenAlexW2121974327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.